BriefCase-Triage vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BriefCase-Triage

by Aidoc Medical

EchoNext

by Pathway Labs

AI Verdict

Both BriefCase-Triage and EchoNext are FDA-cleared AI tools in cardiology and clinical decision support. BriefCase-Triage focuses on prioritizing critical findings across various medical images for radiology workflows, while EchoNext specializes in analyzing standard ECGs to detect hidden structural heart disease. Therefore, BriefCase-Triage is better suited for broad imaging triage, whereas EchoNext is ideal for specific cardiac diagnostic support via ECG analysis.

Choose BriefCase-Triage if…

Choose BriefCase-Triage if your healthcare system requires an AI solution to rapidly prioritize critical findings in various medical images, such as CT scans for intracranial hemorrhage, aortic dissection, or cervical spine fractures. This tool is ideal for enhancing radiology workflow efficiency and ensuring timely intervention for acute conditions by flagging suspected positive findings for review.

View BriefCase-Triage →

Choose EchoNext if…

Choose EchoNext if your practice aims to leverage AI for early detection of hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, using standard 12-lead ECGs. This tool is particularly well-suited for broad screening in various clinical settings, from major hospitals to community practices, to identify at-risk patients who may require further cardiac imaging like echocardiography.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BriefCase-Triage	EchoNext
Pricing	Enterprise	Starts at $600/month
Deployment	Cloud	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated
EHR Integration	Epic	Not specified

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BriefCase-Triage

BriefCase-Triage offers a mobile app for care coordination and seamless integration with existing hospital systems (PACS, EHR). This suggests a more flexible and integrated user experience compared to EchoNext, which is available through a clinical decision support platform. Aidoc's AI is also described as 'always on,' running in the background to identify potential cases, which could streamline workflows for users.

Clinical Value

EchoNext

EchoNext has demonstrated higher accuracy in detecting structural heart disease from ECGs compared to cardiologists, even those with AI assistance. It has also been credited with detecting previously undiagnosed heart failure that led to a heart transplant, highlighting its potential for significant clinical impact.

Pricing & Value

EchoNext

EchoNext provides transparent tiered pricing starting at $600/month, with discounts for annual payments. BriefCase-Triage, on the other hand, requires contacting the vendor for pricing, making its cost less transparent. While both offer discounts, EchoNext's upfront pricing provides clearer value for potential customers.

Enterprise Readiness

BriefCase-Triage

BriefCase-Triage is deployed in over 1,600 hospitals worldwide and offers an enterprise AI operating system (aiOS) that supports multi-condition clinical AI at scale, with built-in governance and continuous performance monitoring. This indicates a robust infrastructure for large-scale deployments and management within health systems. EchoNext, while partnering with OpenEvidence for broad access, does not detail its enterprise-level deployment and management capabilities to the same extent.

Innovation

EchoNext

EchoNext is described as the 'world's first FDA-approved AI detection tool that reads standard 12-lead electrocardiograms (ECGs) to flag high risk structural heart diseases for patients,' and the first AI tool approved by the FDA to detect this kind of hidden heart disease from an ECG. This represents a significant breakthrough in early detection for cardiovascular disease. BriefCase-Triage, while innovative in its comprehensive triage solutions, does not present a comparable 'world-first' claim in its core functionality.

Support & Docs

Tie

Neither product's provided information or web search results offer specific details about their customer support channels, service level agreements, or the comprehensiveness of their documentation. Without this information, it is not possible to definitively pick a winner for this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BriefCase-Triage	EchoNext
Tool Name	BriefCase-Triage	EchoNext
Company	Aidoc Medical	Pathway Labs
Description	FDA-cleared AI solution for physicians, enhancing radiology workflows by rapidly detecting and prioritizing critical findings in medical images.	FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Target Size	Solo to large health systems	Broad access, from major hospitals to community practices.
Key Features	AI-powered analysis of medical imaging, Real-time alerts and notifications, Seamless integration with existing hospital systems (PACS, EHR), Prioritization of critical cases, Order-of-magnitude reduction in false alerts, Comprehensive triage solution (multiple indications in one workflow), Mobile app for care coordination, Continuous learning model	AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support

Videos

Demos, reviews, and walkthroughs featuring BriefCase-Triage and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How deeply do these tools integrate into existing clinical workflows and EHR systems?

BriefCase-Triage offers seamless integration with existing hospital systems like PACS and EHR, and can prioritize cases in a radiologist's worklist. EchoNext is available through the OpenEvidence clinical decision support platform, which is used by many U.S. clinicians, aiming to integrate its screening output directly into existing physician workflows.

What is the accuracy and sensitivity of each tool in detecting critical conditions, and what are their false alert rates?

BriefCase-Triage has demonstrated a mean sensitivity of 97% and a mean specificity of 98% in FDA-reviewed studies for its comprehensive body CT triage solution, with an order-of-magnitude reduction in false alerts compared to single-condition solutions. EchoNext, in a 2025 study, correctly identified 77% of structural heart problems from ECGs alone, outperforming cardiologists who achieved 64% accuracy with the same ECGs.

What is the typical learning curve for physicians and how much training is required for effective use?

While specific learning curve details aren't provided, Aidoc emphasizes its customer success team provides training and educational content to drive hospital-wide adoption and workflow enhancements. EchoNext is designed to integrate into existing workflows via the OpenEvidence platform, suggesting an aim for ease of adoption by leveraging familiar interfaces.

What kind of customer support and resources are available for implementation and ongoing use?

Aidoc provides a customer success team dedicated to training, defining and tracking performance metrics, gathering feedback, and supporting clinical research and adoption. Pathway Labs aims to get EchoNext into real workflows across health systems at a national scale, implying support for implementation.

What are the audit-trail features of each tool, and how do they support accountability and quality improvement?

Aidoc's platform includes continuous performance monitoring and built-in governance, which can contribute to auditability. Aidoc also emphasizes transparent practices and regular audits as part of a robust data governance strategy. The provided information does not detail specific audit-trail features for EchoNext.

How do these tools address multi-site rollout considerations, and what support is offered for larger health systems?

Aidoc's solutions are deployed via its aiOS platform, which is designed to sustain AI performance and impact at foundation-model scale through data normalization and continuous monitoring, enabling health systems to deploy and manage multi-condition clinical AI without re-architecting infrastructure. EchoNext has shown robust performance in studies across over 20 hospitals and 500,000 patients, indicating its suitability for broader deployment.

Beyond the technical specifications, what clinical context should a physician consider when choosing between these tools?

BriefCase-Triage is designed for radiology workflows, rapidly detecting and prioritizing critical findings in medical images across various acute conditions in CT scans, including those in emergency departments and ambulatory settings. EchoNext focuses on cardiology, analyzing standard ECGs to detect hidden structural heart disease, such as heart failure, valve disease, and pulmonary hypertension, aiming for earlier detection of conditions often missed until symptomatic.